Clinical Trials Directory

Trials / Completed

CompletedNCT01877707

Near Patient Microbial Testing in Cystic Fibrosis

A Home-based, Rapid and Quantitative Test for Bacterial Respiratory Infections in Patients With Cystic Fibrosis, to Reduce Admissions and Hospital Stay Length and to Improve Healthcare Outcomes.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Papworth Hospital NHS Foundation Trust · Other Government
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

To identify whether home monitoring of multiple physiological parameters and biomarkers in sputum could provide advanced warning of an infective exacerbation or treatment failure before changes in patient-reported symptoms.

Detailed description

1. To determine if longitudinal profiling of sputum from Cystic Fibrosis patients allow accurate prediction of exacerbations in a study of a larger group and can we confirm the 7+ day early warning system works in this larger group. 2. Is one biomarker sufficient to predict exacerbations - what is the accuracy? Are two or more biomarkers required to achieve an accuracy of greater than 95%? 3. Can we now accurately determine how many hospital bed days a home testing/wellness monitoring device would save? What is the business case for healthcare providers to adopt our future test for home use? We estimate a 50% saving. Can this be confirmed? 4. When used in the clinic, how many hospital days would our test save through faster determination of treatment efficacy? What is the business case for adopting our future test as a point of care test on the ward in Cystic Fibrosis centres? Could this be the new revolutionary tool that we anticipate? 5. We forecast a 50% reduction in costs to treat Cystic Fibrosis patients in disease severity bands 2-A to 5. Can we provide evidence for this to support further investment?

Conditions

Interventions

TypeNameDescription
OTHERhome monitoringRecord daily - peak flow measurements, pulse rate, oxygen saturation levels, weight,activity and daily sputum samples.

Timeline

Start date
2013-01-01
Primary completion
2013-05-01
Completion
2014-06-01
First posted
2013-06-14
Last updated
2016-02-17

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01877707. Inclusion in this directory is not an endorsement.